ОРИГИНАЛЬНЫЕ СТАТЬИ: НАРУШЕНИЯ РИТМА СЕРДЦА
Опубликован 10.10.2015
Ключевые слова
- ФИБРИЛЛЯЦИЯ ПРЕДСЕРДИЙ,
- ИНСУЛЬТ,
- ТРОМБОЭМБОЛИЯ,
- APPENDAGE OCCLUSION
Как цитировать
Ганеева, О. (2015). ОККЛЮЗИЯ УШКА ЛЕВОГО ПРЕДСЕРДИЯ ПРИ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ. Патология кровообращения и кардиохирургия, 18(4), 104–112. https://doi.org/10.21688/1681-3472-2014-4-104-112
Аннотация
Представлен обзор нового метода профилактики тромбоэмболических осложнений при фибрилляции предсердий - окклюзии ушка левого предсердия. Сформулированы показания и противопоказания к данной процедуре, описан ход самого вмешательства. Основное внимание уделено рассмотрению современной доказательной базы и обзору клинических исследований.
Библиографические ссылки
<p>1.
Camm J., Lip G., Caterina R., et al. 2012 ESC Guidelines for the management of atrial fibrillation.
</p>
<p>2.
Holmes D., Reddy V., Turi Z., et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fi brillation: a randomised non-inferiority trial. Lancet. 2009; 374: 534-42.
</p>
<p>3.
Haensig M., Rastan A., Holzher D., et al. Cardiology Research and Practice. 2012; Article ID 149503, 8 p.
</p>
<p>4.
Hart R., Pearce L., Aguilar M. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation. Ann Intern Med. 2007; 146: 857-67.
</p>
<p>5.
Schulman S., Elbazi R., Zondag M., et al. Thrombosis Journal. 2008; 6: 15.
</p>
<p>6.
Capodanno D., Capranzano P., Giacchi G., et al. Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation. A metaanalysis of 50,578 patients. International Journal of Cardiology. IJCA-14637; 5 p.
</p>
<p>7.
Reddy V., Holmes D., Doshi S., et al. Safety of Percutaneous Left Atrial Appendage Closure: Results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients With AF (PROTECT AF) Clinical Trial and the Continued Access Registry. Circulation. 2011; 123: 417-24.
</p>
<p>8.
Holmes D. Jr., Schwartz J. Left atrial appendage occlusion eliminates the need for warfarin. Circulation. 2009; 120: 1919-26.
</p>
<p>9.
Holmes D., Kar S., Price M., et al. Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy. The PREVAIL Trial. J. Am. Coll. Cardiol. 2014; 64: 1-12.
</p>
<p>10.
Kar S., Hou D., Jones R., et al. Impact of Watchman and Amplatzer Devices on Left Atrial Appendage Adjacent Structures and Healing Response in a Canine Model. JACC Cardiovascular Interventions. 2014; 7: 801-9.
</p>
<p>11.
HRS LBCT 2013 by V. Reddy, HH-158101-AA-May 2013
</p>
</p>
<p>1.
Camm J., Lip G., Caterina R., et al. 2012 ESC Guidelines for the management of atrial fibrillation.
</p>
<p>2.
Holmes D., Reddy V., Turi Z., et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fi brillation: a randomised non-inferiority trial. Lancet. 2009; 374: 534-42.
</p>
<p>3.
Haensig M., Rastan A., Holzher D., et al. Cardiology Research and Practice. 2012; Article ID 149503, 8 p.
</p>
<p>4.
Hart R., Pearce L., Aguilar M. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation. Ann Intern Med. 2007; 146: 857-67.
</p>
<p>5.
Schulman S., Elbazi R., Zondag M., et al. Thrombosis Journal. 2008; 6: 15.
</p>
<p>6.
Capodanno D., Capranzano P., Giacchi G., et al. Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation. A metaanalysis of 50,578 patients. International Journal of Cardiology. IJCA-14637; 5 p.
</p>
<p>7.
Reddy V., Holmes D., Doshi S., et al. Safety of Percutaneous Left Atrial Appendage Closure: Results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients With AF (PROTECT AF) Clinical Trial and the Continued Access Registry. Circulation. 2011; 123: 417-24.
</p>
<p>8.
Holmes D. Jr., Schwartz J. Left atrial appendage occlusion eliminates the need for warfarin. Circulation. 2009; 120: 1919-26.
</p>
<p>9.
Holmes D., Kar S., Price M., et al. Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy. The PREVAIL Trial. J. Am. Coll. Cardiol. 2014; 64: 1-12.
</p>
<p>10.
Kar S., Hou D., Jones R., et al. Impact of Watchman and Amplatzer Devices on Left Atrial Appendage Adjacent Structures and Healing Response in a Canine Model. JACC Cardiovascular Interventions. 2014; 7: 801-9.
</p>
<p>11.
HRS LBCT 2013 by V. Reddy, HH-158101-AA-May 2013
</p>
</p>